Sneezing Season, Spending Season: The Evidence Behind What You Actually Need in Your Allergy Toolkit

Every spring, as pollen counts climb and sneezing becomes a shared national experience, something predictable happens in pharmacies and big-box stores across the country. Entire sections are reorganized around the season. End caps fill with immune-support supplements, herbal blends, essential oil diffusers, saline rinses, air purifiers, and specialty teas. Packaging shifts to greens and yellows, invoking nature and vitality. Prices, in many cases, quietly rise.

And American consumers respond. The seasonal wellness market—spanning allergy season in spring, cold and flu season in fall and winter, and the overlapping anxieties in between—generates billions of dollars annually. Some of that spending delivers real relief. Much of it does not. Understanding the difference requires stepping back from the marketing and asking a more disciplined question: what does the clinical evidence actually support?

How the Seasonal Spending Cycle Gets Started

Seasonal health anxiety is not irrational. Pollen allergies affect an estimated 81 million Americans, according to the Asthma and Allergy Foundation of America, making allergic rhinitis one of the most prevalent chronic conditions in the country. Respiratory illness peaks predictably each fall and winter. The desire to do something—to buy something—in response to these seasonal threats is a deeply human impulse.

Marketing teams at wellness and supplement companies understand this impulse precisely. Seasonal campaigns launch weeks before the relevant season begins, seeding the idea that preparation requires purchasing. Phrases like "immune support," "seasonal defense," and "respiratory wellness" appear on products that range from clinically validated to entirely evidence-free. Because the FDA does not require dietary supplements to demonstrate efficacy before reaching store shelves, the burden of evaluating these claims falls on the consumer—who, in the middle of allergy season, may not be in the best position to conduct a literature review.

The result is predictable: shopping carts that contain both genuinely useful products and redundant, unnecessary, or unsupported ones.

What the Evidence Actually Supports for Allergy Season

For seasonal allergic rhinitis—the clinical term for the sneezing, congestion, runny nose, and itchy eyes that most people call hay fever—the evidence base is well established and, importantly, not particularly expensive.

Second-generation oral antihistamines such as cetirizine, loratadine, and fexofenadine are available generically at low cost and have robust clinical support for reducing the histamine-mediated symptoms of seasonal allergies. These medications have largely replaced first-generation antihistamines like diphenhydramine for daytime allergy management because they cause significantly less sedation without sacrificing effectiveness.

Intranasal corticosteroid sprays—including fluticasone propionate and triamcinolone, both available OTC—are considered first-line therapy for moderate to severe allergic rhinitis by major allergy and immunology guidelines. Despite their clinical superiority over antihistamines for nasal congestion, they remain underutilized because they require consistent daily use over several days before full effect is achieved, and consumers accustomed to immediate relief sometimes abandon them prematurely.

Saline nasal irrigation, whether delivered via neti pot or squeeze bottle, has credible evidence supporting its use as an adjunct therapy for symptom relief. It is inexpensive, drug-free, and can improve mucociliary clearance. It is not a replacement for pharmacological treatment in moderate to severe cases, but it is a legitimate addition to an allergy management routine.

These three categories—antihistamines, intranasal corticosteroids, and saline rinses—represent the core of evidence-based OTC allergy management. Everything purchased beyond them should be evaluated carefully.

The Products That Fill Carts Without Filling the Evidence Gap

The supplements and specialty products that proliferate during allergy season occupy a more ambiguous space. Some have plausible mechanisms and limited supporting data. Many have neither.

Quercetin is a flavonoid marketed as a natural antihistamine. In laboratory settings, it inhibits histamine release from mast cells. In human clinical trials, the evidence for meaningful symptom relief in allergic rhinitis is thin and inconsistent. It is not harmful for most people, but the gap between its theoretical mechanism and demonstrated clinical benefit is substantial.

Local honey enjoys persistent popularity as a folk remedy for seasonal allergies, based on the idea that consuming locally sourced pollen gradually desensitizes the immune system. Controlled studies have not supported this claim. Commercial honey is also typically heat-processed in ways that reduce pollen content, and the pollen in honey comes primarily from flowers rather than the wind-borne tree and grass pollens responsible for most seasonal allergies.

High-dose vitamin C and elderberry formulations are marketed with immune-support language during both allergy and cold season. The evidence for vitamin C in reducing allergy symptoms is not compelling at supplemental doses. Elderberry has more interesting data for influenza symptom duration but is frequently marketed for allergy relief, a distinct condition with a different immune mechanism.

Air purifiers occupy a category where the product quality varies enormously and the marketing claims routinely outpace the evidence. HEPA-filter-based units have legitimate support for reducing indoor allergen loads, particularly pet dander and dust mite particles. Ionizing purifiers and many budget models do not meet the same standard. If air quality is a genuine concern, an investment in a quality HEPA unit may be warranted—but it is a targeted purchase, not a seasonal impulse buy.

The Flu and Cold Season Parallel

The same dynamic plays out with cold and flu season spending. Zinc lozenges have some evidence supporting reduced duration of cold symptoms when taken within the first 24 hours of symptom onset—but the effect size is modest and the formulation matters. Vitamin D has a reasonable evidence base for supporting immune function in individuals who are genuinely deficient, but supplementing above sufficient levels does not appear to confer additional benefit. Echinacea studies show inconsistent results across formulations and populations.

The flu vaccine, by contrast, has a well-established evidence base and is available at most pharmacies without an appointment. For adults seeking the single most effective seasonal health intervention, that is where the conversation begins—not the supplement aisle.

A Consumer's Seasonal Checklist

Before adding any seasonal wellness product to your cart, the following questions are worth asking:

• Is this addressing a specific, identified symptom or condition, or am I purchasing it based on general seasonal anxiety?
• What does the clinical evidence say, and is that evidence from human trials or laboratory studies?
• Does this product duplicate something I already have, either in my medicine cabinet or in another product in my basket?
• Is this covered by my HSA or FSA, and if not, am I comfortable with the out-of-pocket cost relative to the evidence supporting it?
• Have I asked a pharmacist whether this product is appropriate for my specific symptom profile and current medications?

Seasonal discomfort is real, and the desire to address it proactively is reasonable. But the pharmacy aisle during peak season is designed to convert that desire into purchases, not all of which will help. Spending less—on the right products—is almost always the more effective strategy.